BRPI1010919A2 - fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos. - Google Patents

fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos.

Info

Publication number
BRPI1010919A2
BRPI1010919A2 BRPI1010919A BRPI1010919A BRPI1010919A2 BR PI1010919 A2 BRPI1010919 A2 BR PI1010919A2 BR PI1010919 A BRPI1010919 A BR PI1010919A BR PI1010919 A BRPI1010919 A BR PI1010919A BR PI1010919 A2 BRPI1010919 A2 BR PI1010919A2
Authority
BR
Brazil
Prior art keywords
feeding
formula
probe containing
nutritionally balanced
standard probe
Prior art date
Application number
BRPI1010919A
Other languages
English (en)
Inventor
Mercenier Annick
Prioult Guénolée
Hélène Nutten Sophie
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42646295&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1010919(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP09159925A external-priority patent/EP2251020A1/en
Priority claimed from EP09159929A external-priority patent/EP2251022A1/en
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI1010919A2 publication Critical patent/BRPI1010919A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/123—Bulgaricus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/231—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BRPI1010919A 2009-05-11 2010-05-11 fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos. BRPI1010919A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09159925A EP2251020A1 (en) 2009-05-11 2009-05-11 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP09159929A EP2251022A1 (en) 2009-05-11 2009-05-11 Non-replicating micro-organisms and their immune boosting effect
PCT/EP2010/056395 WO2010130700A1 (en) 2009-05-11 2010-05-11 Nutritionally balanced standard tube feeding formula containing probiotics

Publications (1)

Publication Number Publication Date
BRPI1010919A2 true BRPI1010919A2 (pt) 2019-09-24

Family

ID=42646295

Family Applications (16)

Application Number Title Priority Date Filing Date
BRPI1012849A BRPI1012849A2 (pt) 2009-05-11 2010-05-07 lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
BRPI1014304A BRPI1014304A2 (pt) 2009-05-11 2010-05-07 bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
BRPI1010919A BRPI1010919A2 (pt) 2009-05-11 2010-05-11 fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos.
BRPI1010926A BRPI1010926A2 (pt) 2009-05-11 2010-05-11 fórmulas para alimentação infantil compreendendo micro-organismos probióticos.
BRPI1010916A BRPI1010916A2 (pt) 2009-05-11 2010-05-11 fórmula nutricional especializada para pacientes adultos com intolerância gastrointestinal contendo probióticos.
BRPI1010917A BRPI1010917A2 (pt) 2009-05-11 2010-05-11 nutrição líquida completa para crianças na idade de 1 a 10 anos compreendendo probióticos.
BRPI1010839A BRPI1010839A2 (pt) 2009-05-11 2010-05-11 suplemento nutricional oral para crianças compreendendo probióticos
BRPI1013733A BRPI1013733A2 (pt) 2009-05-11 2010-05-11 cereais do café da manhã contendo micro-organismos probióticos
BRPI1010637-5A BRPI1010637A2 (pt) 2009-05-11 2010-05-11 suplementos nutricionais orais compreendendo probióticos
BRPI1010802A BRPI1010802A2 (pt) 2009-05-11 2010-05-11 preparações de leite integral seco contendo micro-organismos
BRPI1013731A BRPI1013731A2 (pt) 2009-05-11 2010-05-11 leite de crescimento contendo micro-organismos probioticos
BRPI1010574A BRPI1010574A2 (pt) 2009-05-11 2010-05-11 cereal infantil compreendendo micro-organismos probióticos não replicantes.
BRPI1010929A BRPI1010929A2 (pt) 2009-05-11 2010-05-11 fórmula de alimentação para bebê e crianças jovens compreendendo probióticos para bebês e crianças jovens.
BRPI1010836A BRPI1010836A2 (pt) 2009-05-11 2010-05-11 nutrição medicinal especializada para pacientes cirúrgicos e de trauma contendo probióticos
BRPI1010838A BRPI1010838A2 (pt) 2009-05-11 2010-05-11 espessante imediato compreendendo probióticos para alimentos e bebidas quentes ou frios a serem administrados a pacientes disfágicos
BRPI1010912A BRPI1010912A2 (pt) 2009-05-11 2010-05-11 módulos contendo probióticos para alimentação por sonda.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BRPI1012849A BRPI1012849A2 (pt) 2009-05-11 2010-05-07 lactobacillus johnsonii la1 ncc533 (cncm i-1225) e distúrbios imunes
BRPI1014304A BRPI1014304A2 (pt) 2009-05-11 2010-05-07 bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes

Family Applications After (13)

Application Number Title Priority Date Filing Date
BRPI1010926A BRPI1010926A2 (pt) 2009-05-11 2010-05-11 fórmulas para alimentação infantil compreendendo micro-organismos probióticos.
BRPI1010916A BRPI1010916A2 (pt) 2009-05-11 2010-05-11 fórmula nutricional especializada para pacientes adultos com intolerância gastrointestinal contendo probióticos.
BRPI1010917A BRPI1010917A2 (pt) 2009-05-11 2010-05-11 nutrição líquida completa para crianças na idade de 1 a 10 anos compreendendo probióticos.
BRPI1010839A BRPI1010839A2 (pt) 2009-05-11 2010-05-11 suplemento nutricional oral para crianças compreendendo probióticos
BRPI1013733A BRPI1013733A2 (pt) 2009-05-11 2010-05-11 cereais do café da manhã contendo micro-organismos probióticos
BRPI1010637-5A BRPI1010637A2 (pt) 2009-05-11 2010-05-11 suplementos nutricionais orais compreendendo probióticos
BRPI1010802A BRPI1010802A2 (pt) 2009-05-11 2010-05-11 preparações de leite integral seco contendo micro-organismos
BRPI1013731A BRPI1013731A2 (pt) 2009-05-11 2010-05-11 leite de crescimento contendo micro-organismos probioticos
BRPI1010574A BRPI1010574A2 (pt) 2009-05-11 2010-05-11 cereal infantil compreendendo micro-organismos probióticos não replicantes.
BRPI1010929A BRPI1010929A2 (pt) 2009-05-11 2010-05-11 fórmula de alimentação para bebê e crianças jovens compreendendo probióticos para bebês e crianças jovens.
BRPI1010836A BRPI1010836A2 (pt) 2009-05-11 2010-05-11 nutrição medicinal especializada para pacientes cirúrgicos e de trauma contendo probióticos
BRPI1010838A BRPI1010838A2 (pt) 2009-05-11 2010-05-11 espessante imediato compreendendo probióticos para alimentos e bebidas quentes ou frios a serem administrados a pacientes disfágicos
BRPI1010912A BRPI1010912A2 (pt) 2009-05-11 2010-05-11 módulos contendo probióticos para alimentação por sonda.

Country Status (20)

Country Link
US (18) US10576110B2 (pt)
EP (16) EP2429539B1 (pt)
JP (16) JP5860396B2 (pt)
CN (16) CN102869365A (pt)
AR (2) AR076676A1 (pt)
AU (3) AU2010247469B2 (pt)
BR (16) BRPI1012849A2 (pt)
CA (12) CA2761444C (pt)
CL (1) CL2011002818A1 (pt)
ES (4) ES2559008T3 (pt)
MX (7) MX338680B (pt)
MY (4) MY159273A (pt)
PL (2) PL2429557T3 (pt)
PT (2) PT2429539T (pt)
RU (6) RU2554772C2 (pt)
SG (1) SG175167A1 (pt)
TW (2) TWI402075B (pt)
UA (1) UA109876C2 (pt)
WO (16) WO2010130663A1 (pt)
ZA (4) ZA201109093B (pt)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2559008T3 (es) 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
EP2397145A1 (en) * 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 and immune disorders
ES2565407T3 (es) * 2010-11-05 2016-04-04 Nestec S.A. Procedimiento para la preparación de un producto alimenticio para animales de compañía, el cual contiene microorganismos probióticos
EP2449891A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Drinking yoghurt preparations containing non-replicating probiotic micro-organisms
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2455092A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
JP5821128B2 (ja) * 2011-02-18 2015-11-24 国立大学法人広島大学 大腸粘膜組織の免疫制御組成物
AU2012222340B2 (en) * 2011-03-01 2016-05-12 Société des Produits Nestlé S.A. Extensional viscosity to promote safe swallowing of food boluses
US9309492B2 (en) 2011-03-29 2016-04-12 Nestec S.A. Derivative of the Lactobacilus johnsonii strain CNCM I-1225, deficient in D-lactic acid production and with an improved shelf life
WO2012130968A1 (en) 2011-03-29 2012-10-04 Nestec S.A. Natural derivative of the lactobacilus johnsonii strain cncm i-1225, deficient in d-lactic acid production and with a further improved immune profile
WO2012130965A1 (en) 2011-03-29 2012-10-04 Nestec S.A. Natural derivative of a well known and successful probiotic strain deficient in d-lactic acid production
CN103582698B (zh) 2011-03-29 2016-08-17 雀巢产品技术援助有限公司 缺失d-乳酸产生的约氏乳杆菌菌株cncm i-1225的天然衍生物
BR112013025047A2 (pt) * 2011-03-31 2017-02-14 Nestec Sa composições nutricionais para aumentar os níveis de arginina e métodos para usar as mesmas
RU2748839C2 (ru) * 2011-06-20 2021-05-31 Х.Дж. Хайнц Компани Брэндс Ллк Композиции, способы и наборы для стимулирования мукозальной иммунной системы
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
US20150159066A1 (en) 2011-11-25 2015-06-11 Smith & Nephew Plc Composition, apparatus, kit and method and uses thereof
AU2012351533B2 (en) * 2011-12-15 2016-09-22 Société des Produits Nestlé S.A. Extensional viscosity to promote safe swallowing of food boluses
FR2984352B1 (fr) * 2011-12-16 2018-02-16 Lesaffre Et Compagnie Composition comprenant une biomasse microbienne active
IN2014DN07752A (pt) 2012-02-29 2015-05-15 Ethicon Endo Surgery Inc
US20130344042A1 (en) * 2012-06-20 2013-12-26 Gretchen Tanbonliong Dietary management of celiac disease and food allergy
CN102715235B (zh) * 2012-07-10 2013-09-11 武汉光明乳品有限公司 一种活性植物乳杆菌饮品及其制备方法
CN102949416B (zh) * 2012-11-23 2018-12-11 西安泰科迈医药科技股份有限公司 一种用于改善胃肠道功能的药物组合物及其制备方法
MX2015006312A (es) 2012-11-29 2015-09-07 Nestec Sa Composicion simbiotica y el uso de la misma.
CN103006825A (zh) * 2012-12-21 2013-04-03 林树芳 一种辅助治疗胃病疾患的药膳食品
FR2999932B1 (fr) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2999933B1 (fr) * 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
JP2016506753A (ja) * 2013-02-15 2016-03-07 ネステク ソシエテ アノニム 食品組成物及びその使用
WO2014140606A1 (en) 2013-03-15 2014-09-18 Smith & Nephew Plc Wound dressing and method of treatment
ES2755106T3 (es) * 2013-03-28 2020-04-21 Fresenius Kabi Deutschland Gmbh Composiciones para usar en la nutrición de pacientes con disfagia
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN104120093B (zh) * 2013-04-26 2016-12-28 中国农业大学 长双歧杆菌及其应用以及功能食品组合物及其制备方法
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
EP3033091B1 (en) * 2013-08-16 2022-09-07 Versitech Limited Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma
CN103621633B (zh) * 2013-12-05 2015-02-04 刘保惠 一种婴幼儿系列牦牛奶配方奶粉及其制备方法
CN105960244A (zh) * 2013-12-10 2016-09-21 株式会社明治 抗菌肽诱导剂
CN103636779A (zh) * 2013-12-17 2014-03-19 山东兴牛乳业有限公司 一种功能性发酵乳及其制备方法
FR3020949B1 (fr) * 2014-05-16 2018-02-09 Ecole Normale Superieure De Lyon Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition
CN105176857B (zh) * 2014-06-12 2019-02-12 暨南大学 具有氨苄青霉素抗性的长双歧杆菌及其制剂的制备与应用
JP6868562B2 (ja) 2014-10-31 2021-05-19 ペンデュラム セラピューティクス， インコーポレイテッド 障害の微生物的処置および診断に関する方法および組成物
CN104473292A (zh) * 2014-12-22 2015-04-01 威海百合生物技术股份有限公司 一种婴幼儿益生菌固体饮料
CN108138122B (zh) 2014-12-23 2021-09-21 4D制药研究有限公司 免疫调控
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
US10137164B2 (en) 2015-01-02 2018-11-27 Melaleuca, Inc. Dietary supplement compositions
TWI788111B (zh) 2015-01-02 2022-12-21 美商梅拉洛伊卡公司 多元補充品組成物
TWI790189B (zh) 2015-01-02 2023-01-21 美商梅拉洛伊卡公司 細菌組成物
JP6666053B2 (ja) * 2015-03-31 2020-03-13 雪印メグミルク株式会社 Ｉａｌｄ産生促進剤
CN104770469A (zh) * 2015-04-17 2015-07-15 武汉百信正源生物技术工程有限公司 一种具有增强免疫力功能的酸驴奶的制备方法
DK3292135T3 (da) 2015-05-06 2022-10-31 Univ Wageningen Anvendelse af et polypeptid til at fremkalde immunsignalering og/eller påvirke tarmbarrierefunktion og/eller modulere metabolsk status
EP3294308A4 (en) 2015-05-14 2019-03-06 University of Puerto Rico PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN
SG11201707793YA (en) * 2015-05-29 2017-10-30 Meiji Co Ltd Anticariogenic agent and anticariogenic composition
WO2016203223A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PT3240554T (pt) 2015-06-15 2019-11-04 4D Pharma Res Ltd Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes
DK3307288T3 (da) 2015-06-15 2019-10-07 4D Pharma Res Ltd Sammensætninger omfattende bakteriestammer
CN105166633A (zh) * 2015-07-20 2015-12-23 龚启萍 一种添加益生菌的婴儿米粉的加工方法
JP2018525390A (ja) * 2015-08-31 2018-09-06 ネステク ソシエテ アノニム 抑うつ症状を治療又は予防するための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物
EP3943093A1 (en) 2015-09-10 2022-01-26 Université catholique de Louvain Use of pasteurized akkermansia for treating cancer
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
US20170079310A1 (en) * 2015-09-18 2017-03-23 Richard Gerry Dingman, JR. Texture analog dysphagia cuisine
WO2017060468A1 (en) 2015-10-07 2017-04-13 Galderma Research & Development Composition containing lactic acid bacteria and its use to treat atopic dermatitis
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
PL3209310T3 (pl) 2015-11-20 2018-08-31 4D Pharma Research Limited Kompozycja zawierająca szczepy bakteryjne
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3173373A1 (en) 2015-11-26 2017-05-31 Anheuser-Busch InBev S.A. Polymeric keg connector
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
CN107007632B (zh) * 2016-01-28 2022-05-06 康贝株式会社 用于改善或预防疱疹病毒感染症的组合物
CN105661017A (zh) * 2016-02-03 2016-06-15 程雪娇 一种牲畜饲料及制备方法
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
BR112018067689A2 (pt) 2016-03-04 2019-01-08 4D Pharma Plc composições compreendendo cepas bacterianas do gênero blautia para tratar a hipersensibilidade visceral
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
EP3272396A1 (en) * 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018109018A1 (fr) 2016-12-16 2018-06-21 Nestle Skin Health Sa Capsule comprenant un microorganisme probiotique pour utilisation dans un dispositif de production et de distribution de compositions
WO2018180728A1 (ja) * 2017-03-30 2018-10-04 森永乳業株式会社 炎症制御遺伝子の発現促進用組成物
CN107772264A (zh) * 2017-05-12 2018-03-09 南昌大学 一种具有排汞功能的南瓜果胶排汞婴幼儿米粉的制备方法
KR20200019882A (ko) 2017-05-22 2020-02-25 4디 파마 리서치 리미티드 세균 균주를 포함하는 조성물
TW201907931A (zh) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
ES2917415T3 (es) 2017-06-14 2022-07-08 4D Pharma Res Ltd Composiciones que comprenden una cepa bacteriana
JP6884889B2 (ja) 2017-06-14 2021-06-09 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
FR3070167B1 (fr) * 2017-08-17 2021-12-24 Ecole Normale Superieure Lyon Souches de lactobacillus stimulant la croissance
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
JP7065589B2 (ja) * 2017-10-31 2022-05-12 株式会社明治 ＩＬ－１β血清濃度低下用発酵乳、ＣＸＣＬ１血清濃度低下用発酵乳、癌に伴うＩＬ－１βの過度な血清濃度上昇の抑制用発酵乳、または、癌に伴うＣＸＣＬ１の過度な血清濃度上昇の抑制用発酵乳
CN108013473B (zh) * 2017-11-20 2021-06-18 陕西海升果业发展股份有限公司 一种益生菌冻干块及制备方法以及基于该冻干块的即食水果谷物麦片及制备方法
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
CN108077935A (zh) * 2018-01-22 2018-05-29 广东格物生物科技有限公司 调理中老年人肠道功能菌剂及其制备方法和应用
JP6846376B2 (ja) * 2018-03-15 2021-03-24 キリンホールディングス株式会社 皮膚状態改善用組成物
MX2021003224A (es) * 2018-10-02 2021-05-27 Nestle Sa Combinacion de probioticos para el tratamiento de trastornos gastrointestinales relacionados con la inflamacion.
WO2020113485A1 (zh) * 2018-12-06 2020-06-11 江苏安惠生物科技有限公司 调节肠道菌群的胶囊
CN109628359B (zh) * 2019-02-22 2021-03-02 江南大学 一株可缓解过敏性哮喘的罗伊氏乳杆菌及其应用
TWI729384B (zh) 2019-04-26 2021-06-01 大江生醫股份有限公司 泌尿生殖道保健之益生菌株及其用途
JP7013419B2 (ja) * 2019-08-07 2022-02-15 日清食品ホールディングス株式会社 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌
CN110777087B (zh) * 2019-08-09 2020-08-07 四川厌氧生物科技有限责任公司 一种约氏乳杆菌及其应用
CN110521938A (zh) * 2019-09-12 2019-12-03 广东金海康医学营养品股份有限公司 一种婴幼儿营养米粉及其制备方法
CN110638845B (zh) * 2019-11-08 2020-07-14 爱优诺营养品有限公司 一种菌剂组合物及其在改善厌食症功能性奶粉上的应用
KR102135879B1 (ko) * 2020-02-13 2020-07-21 주식회사 케이티앤지 신규 락토바실러스 플란타룸(Lactobacillus plantarum) KC3 균주를 이용한 면역장애, 호흡기 염증 질환, 알레르기 및 천식의 예방 또는 치료용 조성물 및 이의 용도
WO2022248900A1 (en) * 2021-05-27 2022-12-01 Compagnie Gervais Danone Cereal-based compositions with a mix of galacto-oligosaccharides/fructo- oligosaccharides and uses thereof for improving iron absorption
CN113025540B (zh) * 2021-05-28 2021-10-01 中国食品发酵工业研究院有限公司 用于发酵大豆蛋白的乳酸菌菌剂、制备方法、发酵方法、具有增肌功能的发酵产物
WO2023104887A1 (en) * 2021-12-09 2023-06-15 Société des Produits Nestlé S.A. Lactobacillus acidophilus to increase agmatine production by microbiota
CN115428954A (zh) * 2022-09-15 2022-12-06 北京三元食品股份有限公司 复合益生菌及发酵乳在制备用于辅助治疗hiv患者产品中的应用

Family Cites Families (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456207A (en) * 1972-12-15 1976-11-24 Unilever Ltd Ice-cream
GB2225922B (en) 1988-12-16 1992-10-07 Samuel Kuria Mbugua A method for the manufacture of a fermented cereal product
US4980182A (en) 1989-06-21 1990-12-25 Nestec S.A. Beverages containing a beverage base and milk protein
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5494687A (en) * 1993-11-05 1996-02-27 Polster; Louis S. Process for tenderizing meat
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5549905A (en) * 1994-10-18 1996-08-27 Clintec Nutrition Co. Enternal composition for pediatric patients
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US6194009B1 (en) * 1996-11-22 2001-02-27 Princeton Nutrition, Llc Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula
PT862863E (pt) * 1997-01-09 2002-04-29 Nestle Sa Produto cerealifero contendo probioticos
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6200950B1 (en) * 1998-02-18 2001-03-13 Nestec S.A. Calorically dense nutritional composition
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
DE19860375A1 (de) * 1998-12-28 2000-07-06 Aventis Res & Tech Gmbh & Co Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel
US6120814A (en) * 1999-02-22 2000-09-19 Nature's One, Inc. Organic nutritional formula
EP1034787A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP1034788A1 (en) * 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
BR0008920A (pt) * 1999-03-11 2001-12-18 Nestle Sa Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
FR2795917B1 (fr) 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
CN1281220C (zh) * 1999-10-26 2006-10-25 雀巢制品公司 乳酸菌在制备治疗和/或预防贾第鞭毛虫病药物中的应用
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
MXPA02007018A (es) * 2000-01-18 2002-12-13 Nestle Sa Composicion alimenticia para mascotas para tratamiento de la especie helicobacter en mascotas.
AU783439C (en) * 2000-03-24 2006-12-14 Societe Des Produits Nestle S.A. Use of lactic acid bacterium for the prevention of peritonitis
CA2404381A1 (en) * 2000-04-04 2002-09-26 Shionogi & Co., Ltd. Oily compositions containing highly fat-soluble drugs
US7498162B2 (en) * 2000-09-25 2009-03-03 Nestec S.A. Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
AU2058702A (en) * 2000-10-06 2002-04-15 Nestle Sa Use of probiotic lactic acid bacteria for balancing the skin's immune system
EP1227152A1 (en) * 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
US8263146B2 (en) * 2001-02-19 2012-09-11 Nestec S.A. Consumable product containing probiotics
EP1239032A1 (en) * 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
EP1260227A1 (en) * 2001-05-23 2002-11-27 Societe Des Produits Nestle S.A. Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
EP2260722A3 (en) 2001-08-02 2017-04-05 Simply Thick LLC Process for Preparing Concentrate Thickener Compositions
JP2005526038A (ja) * 2002-02-21 2005-09-02 ソシエテ デ プロデユイ ネツスル ソシエテ アノニム 皮膚の光防護のための経口投与可能な組成物
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
US7105336B2 (en) * 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
AU2003303894A1 (en) * 2003-01-30 2004-08-30 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
CN1183960C (zh) * 2003-02-27 2005-01-12 四川大学 双歧杆菌细胞壁蛋白在制药中的应用
JP4038450B2 (ja) * 2003-03-31 2008-01-23 株式会社バイオテックジャパン 低カロリーご飯並びに低カロリー米及びそれらの製造方法
WO2004112509A2 (en) * 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
DE602004030567D1 (de) * 2003-06-23 2011-01-27 Nestec Sa Säuglingsnährpräparat oder folgemilch
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
RU2543662C2 (ru) * 2003-10-24 2015-03-10 Н.В. Нютрисиа Синбиотическая композиция для детей для профилактики или лечения раздражения кожи от пеленок
ES2531597T3 (es) * 2004-03-04 2015-03-17 E-L Management Corp. Procedimiento de tratamiento de la piel con extracto de Lactobacillus
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
CA2568650C (en) 2004-06-01 2010-04-13 Prophagia Inc. Index and method of use of adapted food compositions for dysphagic persons
AU2005257033B2 (en) * 2004-06-23 2011-05-12 L'oreal Method and compositions useful for preventing and/or treating sensitive and/or dry skin
EP1629850B2 (en) * 2004-08-24 2013-05-22 N.V. Nutricia Nutritional composition comprising indigestible transgalactooligosaccharides and digestible galactose saccharides
JP5371169B2 (ja) * 2004-09-24 2013-12-18 コンビ株式会社 薬剤耐性菌感染防除剤
MX2007004135A (es) * 2004-10-04 2007-06-15 Oreal Composicion cosmetica y/o dermatologica para pieles sensibles.
DE602004013848D1 (de) * 2004-11-12 2008-06-26 Nutricia Nv Flüssige übergangsnahrung für kleinkinder
ES2328702T5 (es) * 2004-11-18 2013-06-14 N.V. Nutricia Composición espesante para pacientes con disfagia
DE602006015438D1 (de) * 2005-02-15 2010-08-26 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
CN101128129A (zh) * 2005-02-28 2008-02-20 纽崔西亚公司 具有益生菌的营养组合物
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
RU2428886C2 (ru) * 2005-04-13 2011-09-20 Нестек С.А. Смесь для грудных детей, содержащая пробиотики
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
BRPI0613805A2 (pt) * 2005-07-20 2011-02-15 Unilever Nv método de preparação de um produto comestìvel e produto comestìvel
WO2007020884A1 (ja) * 2005-08-12 2007-02-22 Meiji Dairies Corporation β－ディフェンシンを介した感染予防効果を有するビフィズス菌または乳酸菌とそれを含有する食品・医薬品組成物
PT1940248E (pt) * 2005-10-05 2010-01-26 Nestec Sa Utilização de uma composição nutricional para promoção do crescimento acelerado
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007050656A2 (en) * 2005-10-24 2007-05-03 Nestec S.A. Dietary fiber formulation and method of administration
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
US7758906B2 (en) 2006-01-20 2010-07-20 Kraft Foods Global Brands Llc Thickening system for products prepared with milk
ES2381211T3 (es) * 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
EP1993576B1 (en) 2006-03-07 2015-10-21 Nestec S.A. Synbiotic mixture
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
PL1915913T3 (pl) 2006-10-23 2016-06-30 Nestec Sa Modulowanie smaku oraz aromatu w mlecznych produktach poprzez biotransformację
BRPI0808052A2 (pt) * 2007-02-28 2014-06-24 Mead Johnson Nutrition Co Método para tratar ou prevenir inflamação sistêmica.
WO2008137181A1 (en) 2007-05-07 2008-11-13 Clearly Superior, Inc Food thickening agent, method for producing food thickening agent
ES2578261T3 (es) 2007-05-18 2016-07-22 Nestec S.A. Lactobacillus johnsonii para prevenir infecciones postoperatorias
JP2008283922A (ja) * 2007-05-18 2008-11-27 Fuji Oil Co Ltd ヨーグルト様飲食品の製造法
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2009005107A1 (ja) * 2007-07-02 2009-01-08 San-Ei Gen F.F.I., Inc. デキストリンを含有する加工食品組成物
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
EP2227239A2 (en) * 2007-12-06 2010-09-15 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CN103263443B (zh) 2007-12-07 2016-09-14 努特里希亚公司 用于尘螨变态反应的双歧杆菌
WO2009075564A1 (en) * 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
PL2072053T3 (pl) * 2007-12-21 2013-02-28 Gervais Danone Sa Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium
US20090162499A1 (en) * 2007-12-21 2009-06-25 The Quaker Oats Company Grain products having a potent natural sweetener and a bulking agent
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
US20120039860A1 (en) * 2008-04-10 2012-02-16 Nestec S.A. Compositions and methods for improved oral health
AR072142A1 (es) 2008-06-13 2010-08-11 Nutricia Nv Nutricion para prevenir infecciones.proceso. composicion. uso.
EP2140772A1 (en) * 2008-07-03 2010-01-06 Nestec S.A. Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
JP2010095465A (ja) 2008-10-16 2010-04-30 House Wellness Foods Kk 乳酸菌含有免疫賦活用組成物
AU2009319257B2 (en) * 2008-11-03 2014-10-09 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
EP2251022A1 (en) 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
ATE546149T1 (de) 2009-05-11 2012-03-15 Nestec Sa Prävention und behandlung von allergischer diarrhöe
ES2559008T3 (es) 2009-05-11 2016-02-10 Nestec S.A. Bifidobacterium longum NCC2705 no replicante y trastornos inmunitarios
EP2251020A1 (en) 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
EP2308498A1 (en) 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
AU2010329990B2 (en) 2009-12-08 2015-07-16 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물

Also Published As

Publication number Publication date
CN102811725A (zh) 2012-12-05
WO2010133475A3 (en) 2011-01-27
JP2012526762A (ja) 2012-11-01
CN103648510A (zh) 2014-03-19
JP2012526754A (ja) 2012-11-01
JP2016006054A (ja) 2016-01-14
WO2010130700A1 (en) 2010-11-18
US9375454B2 (en) 2016-06-28
AR076676A1 (es) 2011-06-29
CN103596578A (zh) 2014-02-19
WO2010133472A3 (en) 2011-02-03
WO2010133475A2 (en) 2010-11-25
RU2549934C2 (ru) 2015-05-10
EP2429546A1 (en) 2012-03-21
CN102595916A (zh) 2012-07-18
ZA201109095B (en) 2015-06-24
EP2429546B1 (en) 2016-08-31
CN102883731A (zh) 2013-01-16
MX339112B (es) 2016-05-12
EP2429538A1 (en) 2012-03-21
WO2010130713A1 (en) 2010-11-18
JP2012526760A (ja) 2012-11-01
PL2429557T3 (pl) 2018-06-29
WO2010130704A1 (en) 2010-11-18
BRPI1010929A2 (pt) 2016-04-05
JP2013526265A (ja) 2013-06-24
US20120189598A1 (en) 2012-07-26
CN102858354B (zh) 2015-06-17
WO2011000620A1 (en) 2011-01-06
MX2011012067A (es) 2011-12-06
WO2010130702A1 (en) 2010-11-18
WO2010130699A1 (en) 2010-11-18
PL2429556T3 (pl) 2017-01-31
ES2608651T3 (es) 2017-04-12
CA2761689A1 (en) 2010-11-18
JP2012526755A (ja) 2012-11-01
CA2761598A1 (en) 2010-11-18
US20130028877A1 (en) 2013-01-31
US20120114701A1 (en) 2012-05-10
EP2429556B1 (en) 2016-03-30
CN102844037A (zh) 2012-12-26
EP2429554A1 (en) 2012-03-21
JP2012526758A (ja) 2012-11-01
EP2429541A1 (en) 2012-03-21
EP2429545A1 (en) 2012-03-21
RU2011150214A (ru) 2013-06-20
US8603492B2 (en) 2013-12-10
US20120183515A1 (en) 2012-07-19
EP2429539B1 (en) 2016-10-12
RU2011150202A (ru) 2013-06-20
US10576110B2 (en) 2020-03-03
CA2761655A1 (en) 2010-11-18
EP2429552A1 (en) 2012-03-21
MX2011012070A (es) 2012-03-07
SG175167A1 (en) 2011-11-28
CN102762216A (zh) 2012-10-31
CN102869365A (zh) 2013-01-09
RU2011150216A (ru) 2013-06-20
CN102695519A (zh) 2012-09-26
BRPI1010916A2 (pt) 2019-09-24
JP2012526751A (ja) 2012-11-01
US8691244B2 (en) 2014-04-08
RU2011150195A (ru) 2013-06-20
BRPI1010838A2 (pt) 2019-09-24
CN102802648A (zh) 2012-11-28
MX341685B (es) 2016-08-30
EP2429553A1 (en) 2012-03-21
BRPI1010926A2 (pt) 2016-04-05
WO2010130710A1 (en) 2010-11-18
RU2556124C2 (ru) 2015-07-10
BRPI1010839A2 (pt) 2016-04-05
US20120195867A1 (en) 2012-08-02
WO2010130701A1 (en) 2010-11-18
US20120107287A1 (en) 2012-05-03
WO2010130662A1 (en) 2010-11-18
EP2429540B1 (en) 2016-07-27
MX2011012066A (es) 2012-03-07
CA2761574A1 (en) 2010-11-18
CA2761687A1 (en) 2010-11-18
AU2010247469B2 (en) 2014-12-18
ZA201109091B (en) 2013-05-29
EP2429540A1 (en) 2012-03-21
CN104220082A (zh) 2014-12-17
RU2011150197A (ru) 2013-06-20
PT2429557E (pt) 2016-06-17
TW201043238A (en) 2010-12-16
RU2564139C2 (ru) 2015-09-27
EP2429543A1 (en) 2012-03-21
WO2010130663A1 (en) 2010-11-18
EP2429539A1 (en) 2012-03-21
AU2010255972A1 (en) 2011-12-08
JP2012526752A (ja) 2012-11-01
BRPI1010637A2 (pt) 2019-04-02
ES2572760T3 (es) 2016-06-02
AU2010247469A1 (en) 2011-12-08
AU2010251313A1 (en) 2011-11-17
BRPI1010836A2 (pt) 2016-04-05
US20120135044A1 (en) 2012-05-31
US20120121561A1 (en) 2012-05-17
CA2761453A1 (en) 2010-11-25
US20120128726A1 (en) 2012-05-24
CA2761691A1 (en) 2010-11-18
WO2010139531A1 (en) 2010-12-09
MX336030B (es) 2016-01-07
ZA201109085B (en) 2013-05-29
CN102858354A (zh) 2013-01-02
US20120121652A1 (en) 2012-05-17
ES2576831T3 (es) 2016-07-11
UA109876C2 (uk) 2015-10-26
MX2011012074A (es) 2012-03-07
JP2012526761A (ja) 2012-11-01
CA2761444A1 (en) 2010-11-18
MX2011012063A (es) 2011-12-06
EP2429551A1 (en) 2012-03-21
JP2012526756A (ja) 2012-11-01
EP2429549A1 (en) 2012-03-21
RU2011150192A (ru) 2013-06-20
BRPI1010574A2 (pt) 2016-03-15
CN103052395A (zh) 2013-04-17
MY173382A (en) 2020-01-21
BRPI1013731A2 (pt) 2019-09-24
CL2011002818A1 (es) 2012-05-11
RU2554772C2 (ru) 2015-06-27
JP2012526529A (ja) 2012-11-01
CA2761573A1 (en) 2010-11-18
AR076677A1 (es) 2011-06-29
CA2761446A1 (en) 2010-11-18
CA2761444C (en) 2018-04-24
CN102917714A (zh) 2013-02-06
EP2429556A2 (en) 2012-03-21
TWI489988B (zh) 2015-07-01
US20120121563A1 (en) 2012-05-17
EP2429548A1 (en) 2012-03-21
TWI402075B (zh) 2013-07-21
JP2013526480A (ja) 2013-06-24
US20120121685A1 (en) 2012-05-17
US8916374B2 (en) 2014-12-23
ZA201109093B (en) 2013-05-29
JP2012526528A (ja) 2012-11-01
MY166552A (en) 2018-07-16
JP2012526757A (ja) 2012-11-01
JP5860396B2 (ja) 2016-02-16
EP2429550A1 (en) 2012-03-21
CN102770145A (zh) 2012-11-07
WO2011000621A1 (en) 2011-01-06
US8784798B2 (en) 2014-07-22
BRPI1010912A2 (pt) 2019-09-24
US20130260440A1 (en) 2013-10-03
WO2010142504A1 (en) 2010-12-16
PT2429539T (pt) 2017-01-12
CA2761449A1 (en) 2010-11-18
EP2429557B1 (en) 2016-05-04
US20120183514A1 (en) 2012-07-19
JP2012526759A (ja) 2012-11-01
BRPI1010917A2 (pt) 2016-03-15
EP2429538B1 (en) 2015-10-21
EP2429557A2 (en) 2012-03-21
BRPI1010802A2 (pt) 2016-04-05
US8802077B2 (en) 2014-08-12
US20120064051A1 (en) 2012-03-15
MX2011012075A (es) 2012-03-07
BRPI1012849A2 (pt) 2018-06-19
WO2010130697A1 (en) 2010-11-18
US20120269789A1 (en) 2012-10-25
MY165388A (en) 2018-03-21
RU2539852C2 (ru) 2015-01-27
TW201100087A (en) 2011-01-01
MX338680B (es) 2016-04-27
CA2761672A1 (en) 2011-01-06
WO2010133472A2 (en) 2010-11-25
CN102939093A (zh) 2013-02-20
ES2559008T3 (es) 2016-02-10
US20120141444A1 (en) 2012-06-07
MY159273A (en) 2016-12-30
US20150079056A1 (en) 2015-03-19
MX2011012064A (es) 2011-12-06
BRPI1014304A2 (pt) 2016-04-05
BRPI1013733A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
BRPI1010919A2 (pt) fórmula para alimentação por sonda padrão nutricionalmente balanceada contendo probióticos.
BR112012001490A2 (pt) aparelho para alimentação.
BRPI0817677A2 (pt) Pó para bebida instantânea
BRPI1011470A2 (pt) suporte á combinação rápida para documentos herdados
BRPI0910399A2 (pt) aparelho para preparar alimento.
BRPI1011309A2 (pt) suporte para cartões
BRPI1011969A2 (pt) esquema pcfich para operação com múltiplas portadoras.
BRPI0922292A2 (pt) semeadora para grãos individuais.
BRPI0909443A2 (pt) colchão para bebês.
BRPI0913873A2 (pt) recipiente para dose única
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
BRPI0812371A2 (pt) Antioxidante para alimentos
FR2942517B1 (fr) Materiau compliant.
BRPI1008706A2 (pt) dispositivo para diagnóstico.
BRPI0924051A2 (pt) Composição nutricional para lactente
ES1068664Y (es) Union mecanica para correas dentadas
DE602008005493D1 (de) Verpackung für riegelartige nahrungsmittel
NO20091539L (no) Fôringsflate
IT1397111B1 (it) Dispositivo per l'alimentazione di fogli.
ES1070615Y (es) Envase flexible para monodosis
ES1064720Y (es) Guia para persiana
TWM387000U (en) Paper feeding mechanism
ES1072150Y (es) Bebedero para ganado
TWM389030U (en) Paper feeding device
ES1070916Y (es) Tolva para maquinas panificadoras.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.